Atrial remodeling in an ovine model of anthracycline-induced nonischemic cardiomyopathy: Remodeling of the same sort

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 2, 2011, Pages 175-182

  Lau, Dennis H ^a   Psaltis, Peter J ^a   MacKenzie, Lorraine ^a   Kelly, Darren J ^b   Carbone, Angelo ^a   Worthington, Michael ^a   Nelson, Adam J ^a   Zhang, Yuan ^b   Kuklik, Pawel ^a   Wong, Christopher X ^a   Edwards, James ^a   Saint, David A ^a   Worthley, Stephen G ^a   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

atrial fibrillation; cardiomyopathy; electrophysiology; heart failure; remodeling

Indexed keywords

DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIAL REMODELING; CARDIOMYOPATHY; CONTROLLED STUDY; ELECTROPLAQUE; HEART ATRIUM; HEART ATRIUM CONDUCTION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REFRACTORY PERIOD; INTRACORONARY INFUSION; NONHUMAN; P WAVE; PRIORITY JOURNAL; SHEEP; STRUCTURE ANALYSIS;

ANIMALS; ANTHRACYCLINES; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; DOXORUBICIN; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; SHEEP;

EID: 79951603488     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01851.x     Document Type: Article

References (36)

1. Middlekauff HR, Stevenson WG, Stevenson LW,: Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991; 84: 40-48.
2. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW,: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998; 32: 695-703. (Pubitemid 28435256)
3. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ,: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925. (Pubitemid 36736633)
4. Power JM, Beacom GA, Alferness CA, Raman J, Wijffels M, Farish SJ, Burrell LM, Tonkin AM,: Susceptibility to atrial fibrillation: A study in an ovine model of pacing-induced early heart failure. J Cardiovasc Electrophysiol 1998; 9: 423-435. (Pubitemid 28183541)
5. Li D, Fareh S, Leung TK, Nattel S,: Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999; 100: 87-95. (Pubitemid 29297945)
6. Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S,: Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 2002; 105: 2672-2678. (Pubitemid 34596046)
7. Lee KW, Everett THt, Rahmutula D, Guerra JM, Wilson E, Ding C, Olgin JE,: Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 2006; 114: 1703-1712. (Pubitemid 44607118)
8. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK,: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084. (Pubitemid 30207690)
9. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA,: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
10. Moe GW, Stopps TP, Howard RJ, Armstrong PW,: Early recovery from heart failure: Insights into the pathogenesis of experimental chronic pacing-induced heart failure. J Lab Clin Med 1988; 112: 426-432.
11. Yamamoto K, Burnett JC, Jr, Meyer LM, Sinclair L, Stevens TL, Redfield MM,: Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol 1996; 271: R1529-R1534.
12. Borenstein N, Bruneval P, Behr L, Laborde F, Montarras D, Daures JP, Derumeaux G, Pouchelon JL, Chetboul V,: An ovine model of chronic heart failure: Echocardiographic and tissue Doppler imaging characterization. J Card Surg 2006; 21: 50-56.
13. Psaltis PJ, Carbone A, Nelson A, Lau DH, Manavis J, Finnie J, Teo KS, Mackenzie L, Sanders P, Gronthos S, Zannettino AC, Worthley SG,: An ovine model of toxic, nonischemic cardiomyopathy-assessment by cardiac magnetic resonance imaging. J Card Fail 2008; 14: 785-795.
14. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Worthington M, Rajendram A, Kelly DR, Nelson AJ, Zhang Y, Kuklik P, Brooks AG, Worthley SG, Faull RJ, Rao MM, Edwards J, Saint DA, Sanders P,: Short term hypertension is associated with the development of atrial fibrillation substrate: A study in an ovine hypertensive model. Heart Rhythm 2010; 7: 396-404.
15. Wijffels MC, Dorland R, Mast F, Allessie MA,: Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 2000; 102: 260-267. (Pubitemid 30451786)
16. Kojodjojo P, Kanagaratnam P, Markides V, Davies DW, Peters N,: Age-related changes in human left and right atrial conduction. J Cardiovasc Electrophysiol 2006; 17: 120-127. (Pubitemid 43344861)
17. Lammers WJ, Schalij MJ, Kirchhof CJ, Allessie MA,: Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol 1990; 259: H1254-H1263. (Pubitemid 20352329)
18. Whipple GH, Sheffield LT, Woodman EG, Theophilis C, Friedman S,: Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 1962; 20: 39-40.
19. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA,: Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107: 2932-2937. (Pubitemid 36736635)
20. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S,: Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001; 104: 2608-2614. (Pubitemid 33104801)
21. Shiroshita-Takeshita A, Brundel BJ, Burstein B, Leung TK, Mitamura H, Ogawa S, Nattel S,: Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res 2007; 74: 75-84. (Pubitemid 46366949)
22. Swain SM, Whaley FS, Ewer MS,: Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 2003; 97: 2869-2879. (Pubitemid 36605157)
23. Feola M, Garrone O, Occelli M, Francini A, Biggi A, Visconti G, Albrile F, Bobbio M, Merlano M,: Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. Int J Cardiol 2010;doi:.
24. Barry E, Alvarez JA, Scully RE, Miller TL, Lipshultz SE,: Anthracycline-induced cardiotoxicity: Course, pathophysiology, prevention and management. Expert Opin Pharmacother 2007; 8: 1039-1058. (Pubitemid 46929299)
25. Singal PK, Iliskovic N,: Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-905. (Pubitemid 28446849)
26. Arnolda L, McGrath B, Cocks M, Sumithran E, Johnston C,: Adriamycin cardiomyopathy in the rabbit: An animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc Res 1985; 19: 378-382. (Pubitemid 15040580)
27. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM,: Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans. Circulation 2003; 108: 1461-1468. (Pubitemid 37176452)
28. Sridhar A, Nishijima Y, Terentyev D, Khan M, Terentyeva R, Hamlin RL, Nakayama T, Gyorke S, Cardounel AJ, Carnes CA,: Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res 2009; 84: 180-181.
29. Workman AJ, Pau D, Redpath CJ, Marshall GE, Russell JA, Norrie J, Kane KA, Rankin AC,: Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm 2009; 6: 445-451.
30. Sanders P, Morton JB, Kistler PM, Spence SJ, Davidson NC, Hussin A, Vohra JK, Sparks PB, Kalman JM,: Electrophysiological and electroanatomic characterization of the atria in sinus node disease: Evidence of diffuse atrial remodeling. Circulation 2004; 109: 1514-1522. (Pubitemid 38420180)
31. John B, Stiles MK, Kuklik P, Chandy ST, Young GD, Mackenzie L, Szumowski L, Joseph G, Jose J, Worthley SG, Kalman JM, Sanders P,: Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J 2008; 29: 2234-2243.
32. Roberts-Thomson KC, John B, Worthley SG, Brooks AG, Stiles MK, Lau DH, Kuklik P, Shipp NJ, Kalman JM, Sanders P,: Left atrial remodeling in patients with atrial septal defects. Heart Rhythm 2009; 6: 1000-1006.
33. Verheule S, Wilson E, Everett T, Shanbhag S, Golden C, Olgin J,: Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 2003; 107: 2615-2622. (Pubitemid 36628945)
34. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH, Dimitri H, Roberts-Thomson KC, Wilson L, De Sciscio P, Young GD, Sanders P,: Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: Characterizing the "second factor". J Am Coll Cardiol 2009; 53: 1182-1191.
35. Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D,: Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008; 51: 828-835. (Pubitemid 351255618)
36. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ,: Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. J Am Coll Cardiol 2005; 45: 1832-1839. (Pubitemid 40789940)